Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced its financial results on Monday for the quarter ended September 30, 2021 reporting revenues of CA$3.52 million ($2.78 million), compared to CA$1.93 million in the same period year ago.
Vertically integrated medical cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced on Wednesday the opening of Zerenia Clinics UK in London as its first International Zerenia clinic in Europe.
During Benzinga Cannabis Capital Conference, several leaders of various cannabis companies gathered to discuss the continuous expansion of the cannabis market outside the U.S.
A vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced Wednesday results from its first research study including 1,453 patients from Khiron-owned Zerenia Clinics.